Qualigen Therapeutics prices $3.46M public offering of common stock and pre-funded warrants

AIxCrypto Holdings, Inc.

Offering: 14,724,058 shares at $0.13 each and pre-funded warrants for 11,972,754 shares at $0.129 per warrant.
Gross proceeds ~$3.46M; closing expected September 6, 2024.
Net proceeds to accelerate payment of $2M Senior Note from July 2024 and fund operations.
Also for clinical/preclinical studies, working capital, possible Marizyme expansion, and acquisitions.
Univest Securities acted as exclusive placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.